Biotechnology News

October 31, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate (TAF; formerly referred to as GS-7340), an investigational novel prodrug of...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics, Inc., a biopharmaceutical company developing and advancing a revolutionary class of drugs called Stapled Peptides, today announced the company’s participation in several upcoming scientific...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present preclinical data on its programs in FAK and PI3K/mTOR at the EORTC-NCI-AACR meeting, November 6-9, 2012 in Dublin, Ireland.

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the 2012 Brean Capital Life Sciences Summit on November 7, 2012 in New York City. In addition, Infinity will be presenting at the Lazard...

October 31, 2012

PARIS--(BUSINESS WIRE)--Mobile payment, identification or urban mobility smart technologies are taking an increasing part of everyday life. Exhibitors from the smart technology industry will make the most of CARTES 2012 Exhibition and Conference...

October 31, 2012

JERUSALEM--(BUSINESS WIRE)--Yissum Research and Development Company of the Hebrew University of Jerusalem, the technology transfer company of the Hebrew University, announced today the inception of its subsidiary, Integra Holdings, a holding...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will host a live webcast of its quarterly conference call at 8:30 a.m. (ET) on Wednesday, November 7, 2012. Harvey J. Berger, M.D., chairman and...

October 31, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today the initiation of a Phase 1b study (Protocol 16009) of TRU-016 in combination with rituximab for patients with previously untreated chronic lymphocytic...

October 31, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that its collaborator, Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, announced that the European...

October 31, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum to host a teleconference and webcast with management to discuss the third quarter 2012 financial results, provide an update on the Company's business, and discuss expectations for the future

October 31, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions today announced its financial results for the third quarter of 2012, and provided detailed financial guidance for the fourth quarter and full year 2012.

October 31, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--EnVivo Pharmaceuticals Presents Additional EVP-6124 Phase 2b Clinical Trial Results at the Clinical Trials on Alzheimer’s Disease (CTAD) Meeting

October 31, 2012

MANCHESTER, England--(BUSINESS WIRE)--Gentronix Limited, the genotoxicity innovation and service company, has received French research tax credit approval for years 2012 through 2014.

October 31, 2012

NEW YORK & UXBRIDGE, United Kingdom--(BUSINESS WIRE)--Medidata Solutions was selected by Sanofi as the clinical technology standard for clinical data collection, management and reporting and performance-enhancing analytics across entire R...

October 31, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the third quarter ended September 30, 2012. “We were pleased with AMPYRA’s performance in the third quarter, with net sales of $69....

October 31, 2012

SAN DIEGO--(BUSINESS WIRE)--DaVita will present 13 abstracts at the American Society of Nephrology (ASN) Kidney Week in San Diego, November 1-4. Attendees can find DaVita representatives in booth #1903.

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced the Company’s sponsorship...

October 31, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only Widely anticipated results from RELY-ABLE®, the first long-term follow-up study of a novel oral anticoagulant treatment for stroke prevention in AF, will be...

October 31, 2012

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Millennium and Takeda announce European Commission marketing authorization for ADCETRIS in relapsed or refractroy HL and relapsed and refractory sALCL.

October 31, 2012

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda and Millennium today announced that the European Commission (EC) has granted conditional marketing authorisation for ADCETRIS in relapsed/refractory HL and relapsed or refractory sALCL...

October 31, 2012

VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: FIRST NINE MONTHS • Net revenue increased by nine percentage points and amounted to SEK 15.6 million (14.3). • The net loss after tax totaled SEK 10.2 million (11.9). This respresented an...

October 31, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: As previously announced, the number of shares and votes in Precise Biometrics (STO:PREC) has increased following a rights issue. With reference to chapter 4 section 9 (1991:980) of the Swedish...

October 31, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med finansiella instrument” it’s hereby announced that through the subscription by exercise of options in Aerocrine the number...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Inspiration Biopharmaceuticals, Inc. (Inspiration), a biopharmaceutical company dedicated solely to the development of products for hemophilia, today announced that it has filed for protection under Chapter 11...

October 31, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that Inspiration Biopharmaceuticals Inc. (Inspiration) has commenced a voluntary reorganization case pursuant to Chapter 11’s provisions of the United...

October 30, 2012

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter ended September...

October 30, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories issues third-quarter 2012 financial results

October 30, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its fourth...

October 30, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to acquire majority ownership of Vital River, the premier commercial provider of research models and related services in China

October 30, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $51.3 million for the third...

October 30, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX) today announced that the company has rescheduled the issuance of third quarter 2012 operating results and the associated conference call to after market close on Monday...

October 30, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. today reported financial results for its fiscal first quarter ended September 30, 2012.

October 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the 2012 Baird Industrial Conference being held...

October 30, 2012

PARIS--(BUSINESS WIRE)--AB Science reports phase 3 study results of masitinib in combination with Gemzar® for treatment of pancreatic cancer

October 30, 2012

LISLE, Ill.--(BUSINESS WIRE)--Molex Adds Innovative Products To its MediSpec™ Portfolio Demonstrating Commitment to Global Medical Electronics

October 30, 2012

CARY, N.C.--(BUSINESS WIRE)--ISR surveyed 100 Principal Investigators and Site-coordinators across 11 therapeutic areas to compare the level of compensation paid to investigator sites for participation in a clinical study.

October 30, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Extraordinary General Meeting of Diamyd Medical AB (publ)(STO:DIAMB)(Pink Sheets:DMYDY) held today decided in accordance with the Board's resolution, to approve the agreement to sell all shares in...

October 30, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--US-based drug companies spend an average $237,000 on each of their medical science liaisons (MSLs).

October 30, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of asthma, surveyed physicians’ prescribing practices of LABA/...

October 30, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Class action lawsuits have been filed against Peregrine Pharmaceuticals for alleged violations of U.S. securities laws; owners of Peregrine securities can move to become lead plaintiff by 11/27/12.

October 30, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Announces FDA Acceptance of Two sNDAs for the Use of Latuda as Monotherapy and Adjunctive Therapy in Adult Patients with Depressive Episodes Associated with Bipolar I Disorder

October 30, 2012

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended September 30, 2012. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share,...

October 30, 2012

ROCHESTER, N.Y--(BUSINESS WIRE)--Carestream new lesion management software--just cleared by the FDA--makes it faster and easier for radiologists to measure and compare lesions, as well as tumors and other anatomical structures.

October 30, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Swedish specialty pharmaceutical company Orexo (STO:ORX) today communicated the start of the dose finding study for OX51 in patients undergoing prostate biopsy. Results from the study, which is a...

October 30, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The company’s partner, Intercede has developed the new MyID® CardChecker™ App, compatible with Precise Biometrics’ (STO:PREC) Tactivo™ smart card and fingerprint reader for the iPhone and iPad. With...

October 30, 2012

BISHOPS STORTFORD, England--(BUSINESS WIRE)--Dotmatics Limited, a leading supplier of scientific informatics solutions to the Biotech industry, announces that Spermatech AS, has selected the Dotmatics Platform to manage their scientific data.

October 30, 2012

MILFORD, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the new Thermo Scientific Sorvall LYNX superspeed centrifuge series, delivering productivity, safety and reliability to maximize...

October 30, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today reported third quarter 2012 financial results. Adjusted net income increased $15.3 million to $32.5 million in the third quarter 2012, or $0.48 per diluted share,...